A few drops of blood taken moments after birth could change the course of a child’s life – and families in Garston now have the chance to be a part of that breakthrough.
West Hertfordshire Teaching Hospitals NHS Trust announced on Tuesday, January 20, that it joined the world-leading Generation Study, led by Genomics England in partnership with NHS England.
The project screens 100,000 newborns for more than 200 rare genetic conditions. Researchers use genome sequencing from a small blood sample taken from the umbilical cord shortly after birth.
By identifying possible conditions at the start of life, parents receive answers sooner while future generations benefit from advances in early diagnosis and care.
Doctor Avinash Jinadatha, principal investigator at the Trust, said: “Early detection of treatable genetic conditions can make a real difference, helping children stay healthier and access the right care sooner.”
Expectant parents are told about the study during pregnancy and can discuss it with a healthcare professional before deciding whether to take part.
Find out more at www.generationstudy.co.uk
0 Comments